Logo-apb
Adv Pharm Bull. 2018;8(3): 377-382. doi: 10.15171/apb.2018.044
PMID: 30276133        PMCID: PMC6156490

Mini Review

Isotretinoin; A review on the Utilization Pattern in Pregnancy

Sajad Khiali 1 ORCID, Afshin Gharekhani 2 ORCID, Taher Entezari-Maleki 2 * ORCID

Cited by CrossRef: 8


1- Ibrahim S, Gaborit B, Lenoir M, Collod-Beroud G, Stefanovic S. Maternal Pre-Existing Diabetes: A Non-Inherited Risk Factor for Congenital Cardiopathies. IJMS. 2023;24(22):16258 [Crossref]
2- Kalisch-Smith J, Ved N, Sparrow D. Environmental Risk Factors for Congenital Heart Disease. Cold Spring Harb Perspect Biol. 2020;12(3):a037234 [Crossref]
3- Andersen J, Futtrup T. Drugs in pregnancy. 2020;321(1):1243 [Crossref]
4- Carmody K, Rouse M, Nolan D, Quinlan D. GPs’ practice and attitudes to initiating isotretinoin for acne vulgaris in Ireland: a cross-sectional questionnaire survey in primary care. Br J Gen Pract. 2020;70(698):e651 [Crossref]
5- Al-Mekhlafi R, Attiyah R, Haddad Y, Salah L, Gbolade B. Awareness on Teratogenic Effects of Isotretinoin and Compliance with Precautionary Measures among Women of Childbearing Age in Makkah Province, Saudi Arabia. Obstetrics and Gynecology International. 2021;2021:1 [Crossref]
6- Manfredini M, Di Castri L, Grandi G. Let’s reconsider modern progestin-only pills during isotretinoin and retinoid therapy. The European Journal of Contraception & Reproductive Health Care. 2024;:1 [Crossref]
7- Oliveira C, Almeida L, Bonamigo R, Lima C, Bagatin E. Consensus on the therapeutic management of rosacea – Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia. 2020;95:53 [Crossref]
8- Hosseinpour P, Gholamabbas G, Pezeshkian F, Erfani A, Shahriarirad R, Parhizkar A. Practice and attitude of general practitioners towards initiating isotretinoin for acne vulgaris in Fars province, Iran: cross-sectional study. BMC Prim Care. 2024;25(1) [Crossref]
9- Altıntaş Aykan D, Ergün Y. Isotretinoin: Still the cause of anxiety for teratogenicity. Dermatologic Therapy. 2020;33(1) [Crossref]
10- Durán C, Riera-Arnau J, Abtahi S, Pajouheshnia R, Hoxhaj V, Gamba M, Alsina E, Martin-Perez M, Garcia-Poza P, Llorente-Garcia A, Gonzalez-Bermejo D, Ibánez L, Sabaté M, Vidal X, Ballarín E, Sanfélix-Gimeno G, Rodríguez-Bernal C, Peiró S, García-Sempere A, Sanchez-Saez F, Ientile V, Ingrasciotta Y, Guarneri C, Tanaglia M, Tari M, Herings R, Houben E, Swart-Polinder K, Holthuis E, Huerta C, Gini R, Roberto G, Bartolini C, Paoletti O, Limoncella G, Girardi A, Hyeraci G, Andersen M, Kristiansen S, Hallgreen C, Klungel O, Sturkenboom M. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis. Front Pharmacol. 2023;14 [Crossref]
11- Bastos Maia S, Rolland Souza A, Costa Caminha M, Lins da Silva S, Callou Cruz R, Carvalho dos Santos C, Batista Filho M. Vitamin A and Pregnancy: A Narrative Review. Nutrients. 2019;11(3):681 [Crossref]